MXPA02010600A - Inhibidor del intercambiador de sodio-hidrogeno de tipo 1. - Google Patents

Inhibidor del intercambiador de sodio-hidrogeno de tipo 1.

Info

Publication number: MXPA02010600A
Authority: MX; Mexico
Prior art keywords: compound; tissue; prodrug; pharmaceutically acceptable; acceptable salt
Prior art date: 2000-04-28

Application number

MXPA02010600A

Other languages

English (en)

Spanish (es)

Inventor

Eric David Cox

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-28

Filing date

2001-02-28

Publication date

2003-03-10

2001-02-28 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2003-03-10 Publication of MXPA02010600A publication Critical patent/MXPA02010600A/es

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Treatment Of Water By Ion Exchange (AREA)
Preventing Corrosion Or Incrustation Of Metals (AREA)
Plural Heterocyclic Compounds (AREA)

MXPA02010600A 2000-04-28 2001-02-28 Inhibidor del intercambiador de sodio-hidrogeno de tipo 1. MXPA02010600A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US20043200P	2000-04-28	2000-04-28
PCT/IB2001/000277 WO2001083470A1 (en)	2000-04-28	2001-02-28	Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)

Publications (1)

Publication Number	Publication Date
MXPA02010600A true MXPA02010600A (es)	2003-03-10

Family

ID=22741697

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA02010600A MXPA02010600A (es)	2000-04-28	2001-02-28	Inhibidor del intercambiador de sodio-hidrogeno de tipo 1.

Country Status (40)

Country	Link
EP (1)	EP1276737A1 (et)
JP (1)	JP2003531900A (et)
KR (1)	KR20020093079A (et)
CN (1)	CN1225466C (et)
AP (1)	AP2002002651A0 (et)
AR (1)	AR028375A1 (et)
AU (1)	AU2001235896A1 (et)
BG (1)	BG107139A (et)
BR (1)	BR0110268A (et)
CA (1)	CA2407535A1 (et)
CO (1)	CO5221125A1 (et)
CR (1)	CR6797A (et)
CZ (1)	CZ20023408A3 (et)
DZ (1)	DZ3310A1 (et)
EA (1)	EA004882B1 (et)
EE (1)	EE200200615A (et)
GT (1)	GT200100064A (et)
HN (1)	HN2001000042A (et)
HR (1)	HRP20020851A2 (et)
HU (1)	HUP0300651A2 (et)
IL (1)	IL152075A0 (et)
IS (2)	IS6567A (et)
MA (1)	MA26897A1 (et)
MX (1)	MXPA02010600A (et)
MY (1)	MY133842A (et)
NO (1)	NO20025132L (et)
NZ (1)	NZ521348A (et)
OA (1)	OA12256A (et)
PA (1)	PA8513301A1 (et)
PE (1)	PE20011270A1 (et)
PL (1)	PL357765A1 (et)
SK (1)	SK14872002A3 (et)
SV (1)	SV2002000418A (et)
TN (1)	TNSN01065A1 (et)
TR (1)	TR200202439T2 (et)
UA (1)	UA73348C2 (et)
UY (1)	UY26680A1 (et)
WO (1)	WO2001083470A1 (et)
YU (1)	YU79602A (et)
ZA (1)	ZA200208605B (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL156220A0 (en) *	2001-01-31	2003-12-23	Pfizer Prod Inc	Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
MXPA04004685A (es) *	2001-12-19	2004-08-12	Pfizer Prod Inc	Procedimientos para preparar inhibidores de tipo-1 de intercambiador sodio-hidrogeno.
EP1499317A1 (en) *	2002-05-02	2005-01-26	Pfizer Products Inc.	Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (fr) *	2002-06-03	2004-07-16	Aventis Pharma Sa	Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) *	2002-07-16	2006-04-01	Consejo Sup. De Investig. Cientificas	Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
JP2006517976A (ja) *	2003-02-14	2006-08-03	スミスクライン・ビーチャム・コーポレイション	新規化合物
RU2518741C1 (ru) *	2013-03-22	2014-06-10	Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ"	СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20030078886A (ko) *	1998-02-27	2003-10-08	화이자 프로덕츠 인크.	허혈 치료용 ｎ-[(치환된 5원 트리아자 이불포화고리)카르보닐] 구아니딘 유도체

2001
- 2001-02-28 KR KR1020027014355A patent/KR20020093079A/ko not_active Abandoned
- 2001-02-28 CN CNB018087256A patent/CN1225466C/zh not_active Expired - Fee Related
- 2001-02-28 SK SK1487-2002A patent/SK14872002A3/sk unknown
- 2001-02-28 HR HR20020851A patent/HRP20020851A2/hr not_active Application Discontinuation
- 2001-02-28 EE EEP200200615A patent/EE200200615A/et unknown
- 2001-02-28 EA EA200201023A patent/EA004882B1/ru not_active IP Right Cessation
- 2001-02-28 WO PCT/IB2001/000277 patent/WO2001083470A1/en not_active Ceased
- 2001-02-28 EP EP01908037A patent/EP1276737A1/en not_active Withdrawn
- 2001-02-28 HU HU0300651A patent/HUP0300651A2/hu unknown
- 2001-02-28 YU YUP-796/02A patent/YU79602A/sh unknown
- 2001-02-28 PL PL01357765A patent/PL357765A1/xx not_active Application Discontinuation
- 2001-02-28 AP APAP/P/2002/002651A patent/AP2002002651A0/en unknown
- 2001-02-28 TR TR2002/02439T patent/TR200202439T2/xx unknown
- 2001-02-28 CZ CZ20023408A patent/CZ20023408A3/cs unknown
- 2001-02-28 UA UA2002108497A patent/UA73348C2/uk unknown
- 2001-02-28 BR BR0110268-0A patent/BR0110268A/pt not_active IP Right Cessation
- 2001-02-28 IL IL15207501A patent/IL152075A0/xx unknown
- 2001-02-28 NZ NZ521348A patent/NZ521348A/en unknown
- 2001-02-28 DZ DZ013310A patent/DZ3310A1/fr active
- 2001-02-28 MX MXPA02010600A patent/MXPA02010600A/es active IP Right Grant
- 2001-02-28 CA CA002407535A patent/CA2407535A1/en not_active Abandoned
- 2001-02-28 AU AU2001235896A patent/AU2001235896A1/en not_active Abandoned
- 2001-02-28 JP JP2001580898A patent/JP2003531900A/ja active Pending
- 2001-02-28 OA OA1200200331A patent/OA12256A/en unknown
- 2001-03-06 HN HN2001000042A patent/HN2001000042A/es unknown
- 2001-03-12 PA PA20018513301A patent/PA8513301A1/es unknown
- 2001-04-20 GT GT200100064A patent/GT200100064A/es unknown
- 2001-04-24 UY UY26680A patent/UY26680A1/es not_active Application Discontinuation
- 2001-04-26 AR ARP010101970A patent/AR028375A1/es unknown
- 2001-04-26 MY MYPI20011977A patent/MY133842A/en unknown
- 2001-04-26 PE PE2001000376A patent/PE20011270A1/es not_active Application Discontinuation
- 2001-04-27 TN TNTNSN01065A patent/TNSN01065A1/fr unknown
- 2001-04-27 SV SV2001000418A patent/SV2002000418A/es not_active Application Discontinuation
- 2001-04-27 CO CO01032977A patent/CO5221125A1/es not_active Application Discontinuation
2002
- 2002-09-23 BG BG107139A patent/BG107139A/bg unknown
- 2002-09-24 IS IS6567A patent/IS6567A/is unknown
- 2002-10-18 MA MA26875A patent/MA26897A1/fr unknown
- 2002-10-18 CR CR6797A patent/CR6797A/es not_active Application Discontinuation
- 2002-10-21 IS IS6588A patent/IS6588A/is unknown
- 2002-10-24 ZA ZA200208605A patent/ZA200208605B/en unknown
- 2002-10-25 NO NO20025132A patent/NO20025132L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20025132D0 (no)	2002-10-25
PE20011270A1 (es)	2001-12-12
CO5221125A1 (es)	2002-11-28
IS6567A (is)	2002-09-24
IL152075A0 (en)	2003-05-29
EA004882B1 (ru)	2004-08-26
PL357765A1 (en)	2004-07-26
GT200100064A (es)	2002-03-22
CA2407535A1 (en)	2001-11-08
WO2001083470A1 (en)	2001-11-08
CR6797A (es)	2004-05-17
CN1426404A (zh)	2003-06-25
JP2003531900A (ja)	2003-10-28
TNSN01065A1 (fr)	2005-11-10
MY133842A (en)	2007-11-30
NO20025132L (no)	2002-12-12
AR028375A1 (es)	2003-05-07
CZ20023408A3 (cs)	2004-01-14
UY26680A1 (es)	2001-12-28
HN2001000042A (es)	2001-07-09
ZA200208605B (en)	2003-10-24
CN1225466C (zh)	2005-11-02
EA200201023A1 (ru)	2003-02-27
UA73348C2 (en)	2005-07-15
AP2002002651A0 (en)	2002-12-31
OA12256A (en)	2003-11-06
AU2001235896A1 (en)	2001-11-12
MA26897A1 (fr)	2004-12-20
YU79602A (en)	2006-05-25
HUP0300651A2 (hu)	2003-07-28
IS6588A (is)	2002-10-21
SV2002000418A (es)	2002-07-03
EE200200615A (et)	2004-04-15
NZ521348A (en)	2004-09-24
EP1276737A1 (en)	2003-01-22
TR200202439T2 (tr)	2003-02-21
KR20020093079A (ko)	2002-12-12
SK14872002A3 (sk)	2004-03-02
DZ3310A1 (fr)	2001-11-07
BR0110268A (pt)	2003-12-30
HRP20020851A2 (en)	2005-02-28
PA8513301A1 (es)	2003-09-05
BG107139A (bg)	2003-07-31

Publication	Publication Date	Title
US9643928B2 (en)	2017-05-09	Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid
MXPA02010600A (es)	2003-03-10	Inhibidor del intercambiador de sodio-hidrogeno de tipo 1.
US6852733B2 (en)	2005-02-08	Sodium-hydrogen exchanger type 1 inhibitor
EP1224179B1 (en)	2004-07-14	Sodium-hydrogen exchanger type 1 inhibitor crystals
US6441176B1 (en)	2002-08-27	Method for preparing sodium-hydrogen exchanger type 1 inhibitor
HK1056723A (en)	2004-02-27	Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
AU2005201428A1 (en)	2005-04-28	Method for preparing sodium-hydrogen exchanger type 1 inhibitor

Legal Events

Date	Code	Title	Description
2005-10-21	FG	Grant or registration